Congressional Digest

Supreme Court Debates April 2024 No. 4 Vol. 27
Bump Stock Ban, Presidential Immunity and Social Media Regulation on the Docket

The Abortion Pill

The Legality of the FDA’s Drug Approval Process

Buy Complete Issue$19.95

Bump Stock Ban, Presidential Immunity and Social Media Regulation on the Docket

Garland v. Cargill, Trump v. United States, Moody v. NetChoice and Others

Below is the status of key cases granted certiorari by the U.S. Supreme Court for consideration during the October 2023 (Oct. 2, 2023, to Oct. 6, 2024) term, as of March 27, 2024. Cases are organized by certiorari date within each section.  Abortion Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine — This case was granted certiorari on Dec. 13, 2023, and was argued on March 26, 2024. At issue is whether the FDA approval of and subsequent rulemaking for the abortion drug mifepristone was “arbitrary and capricious” in violation of federal law. Featured in The Abortion Pill,…

Back to top ↑
X
Username
Password

Email Address
Email Address Again
Forgot username/password?